BlackRock’s CervoMed CRVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $654K | Sell |
104,049
-244,574
| -70% | -$1.54M | ﹤0.01% | 4313 |
|
|
2025
Q1 | $3.19M | Buy |
348,623
+24,315
| +7% | +$222K | ﹤0.01% | 3783 |
|
|
2024
Q4 | $759K | Buy |
324,308
+5,542
| +2% | +$13K | ﹤0.01% | 4247 |
|
|
2024
Q3 | $4.65M | Buy |
318,766
+14,831
| +5% | +$217K | ﹤0.01% | 3679 |
|
|
2024
Q2 | $5.2M | Buy |
303,935
+282,119
| +1,293% | +$4.83M | ﹤0.01% | 3620 |
|
|
2024
Q1 | $508K | Sell |
21,816
-84
| -0.4% | -$1.96K | ﹤0.01% | 4310 |
|
|
2023
Q4 | $167K | Hold |
21,900
| – | – | ﹤0.01% | 4609 |
|
|
2023
Q3 | $101K | Sell |
21,900
-1
| -0% | -$5 | ﹤0.01% | 4777 |
|
|
2023
Q2 | $110K | Hold |
21,901
| – | – | ﹤0.01% | 4795 |
|
|
2023
Q1 | $136K | Hold |
21,901
| – | – | ﹤0.01% | 4807 |
|
|
2022
Q4 | $166K | Hold |
21,901
| – | – | ﹤0.01% | 4817 |
|
|
2022
Q3 | $176K | Hold |
21,901
| – | – | ﹤0.01% | 4917 |
|
|
2022
Q2 | $219K | Sell |
21,901
-2
| -0% | -$20 | ﹤0.01% | 4915 |
|
|
2022
Q1 | $411K | Hold |
21,903
| – | – | ﹤0.01% | 4839 |
|
|
2021
Q4 | $501K | Buy |
21,903
+85
| +0.4% | +$1.94K | ﹤0.01% | 4798 |
|
|
2021
Q3 | $834K | Hold |
21,818
| – | – | ﹤0.01% | 4541 |
|
|
2021
Q2 | $1.2M | Sell |
21,818
-5,441
| -20% | -$298K | ﹤0.01% | 4387 |
|
|
2021
Q1 | $1.88M | Buy |
27,259
+16,186
| +146% | +$1.11M | ﹤0.01% | 4238 |
|
|
2020
Q4 | $660K | Hold |
11,073
| – | – | ﹤0.01% | 4223 |
|
|
2020
Q3 | $699K | Hold |
11,073
| – | – | ﹤0.01% | 4096 |
|
|
2020
Q2 | $810K | Buy |
11,073
+129
| +1% | +$9.44K | ﹤0.01% | 4011 |
|
|
2020
Q1 | $260K | Hold |
10,944
| – | – | ﹤0.01% | 4109 |
|
|
2019
Q4 | $378K | Buy |
+10,944
| New | +$378K | ﹤0.01% | 4146 |
|
|
2018
Q2 | – | Sell |
-14
| Closed | -$9K | – | 4962 |
|
|
2018
Q1 | $9K | Hold |
14
| – | – | ﹤0.01% | 4615 |
|
|
2017
Q4 | $19K | Hold |
14
| – | – | ﹤0.01% | 4516 |
|
|
2017
Q3 | $26K | Hold |
14
| – | – | ﹤0.01% | 4494 |
|
|
2017
Q2 | $38K | Buy |
+14
| New | +$38K | ﹤0.01% | 4491 |
|